| HER2-Low Breast Cancer |
1 |
1 |
| Biologic Therapy |
0 |
0.89 |
| Breast Cancer |
0 |
0.89 |
| Advanced and Metastatic Breast Cancer |
0 |
0.83 |
| Cancer |
0 |
0.7 |
| Antineoplastic Drug |
0 |
0.57 |
| Targeted Cancer Therapy |
0 |
0.54 |
| Chemotherapy |
0 |
0.51 |
| Toxicology |
0 |
0.48 |
| Genomic Medicine |
0 |
0.41 |
| Adjuvant Chemotherapy |
0 |
0.39 |
| Breast |
0 |
0.39 |
| Antibody Drug Conjugates |
0 |
0.99 |
| Hodgkin Lymphoma |
0 |
0.14 |
| Humanized Monoclonal Antibody |
0 |
0.13 |
| Immunohistochemistry |
0 |
0.12 |
| Tumor |
0 |
0.12 |
| Interstitial Lung Disease |
0 |
0.11 |
| Lung |
0 |
0.08 |
| Monoclonal Antibody |
0 |
0.08 |
| Epidermal Growth Factor Receptor |
0 |
0.06 |